Table 3.
Type of secreted factors | MSC source | Method for aggregation | Trophic factor detected | Ref. |
---|---|---|---|---|
Anti-inflammatory | Human bone marrow | Hanging drop | 500- to 1000-fold increase in TSG-6, and 300-fold PGE2 expression | 5,18 |
Human adipose tissue | Hanging drop | Fivefold increase in SDF-1 expression | 79 | |
Tumor suppressor | Human bone marrow | Low attachment plates | 75-fold increase in IL-24 expression | 6 |
Chemotactic receptor | Human bone marrow | Hanging drop | 35% increase in CXCR4 expression | 37 |
Human gingiva | Low attachment plates | 35% increase in CXCR4 expression compared to 2D | 12 | |
Proangiogenic | Human umbilical cord | Low attachment plates | Threefold increase in VEGF | 59 |
Human gingiva | Low attachment plates | Three to fivefold increase in MCP-2, MCP-3, RANTES, M-CSF, EGF, VEGF, SDF-1, and angiogenin expression | 12 | |
Human adipose tissue | Spinner flask | 5- to 10-fold increase in FGF-2, HGF, and VEGF expression compared to dissociated cells | 38 | |
Human adipose tissue | Hanging drop | 23-fold increase in angiopoietin-like 2 expression | 79 |
TSG-6, TNF-stimulated gene 6 protein; PGE2, prostaglandin E2; IL-24, interleukin-24; CXCR4, C-X-C chemokine receptor type 4; VEGF, vascular endothelial growth factor; MCP-2, monocyte chemotactic protein 2; RANTES, regulated on activation, normal T cell expressed and secreted; M-CSF, macrophage colony-stimulating factor; EGF, epithelial growth factor; SDF-1, stromal cell-derived factor 1; FGF-2, fibroblast growth factor 2; HGF, hepatocyte growth factor.